Search - tctmd.com

Displaying 41 - 60 of 97

Presentation TCT 2018

Case #4 A Patient With a Vulnerable Plaque Who Developed a Late Event

Presenter: James E. Muller, Yoshinobu Onuma, Peter H. Stone, Takashi Akasaka, David Erlinge, Hector M. Garcia-Garcia, Guillermo Tearney, Ron Waksman

September 23, 2018

Presentation TCT 2018

Case #3 Vulnerable Plaque and Peri-Procedural Myocardial Infarction: I Should Have Used Protection

Presenter: James E. Muller, Yoshinobu Onuma, Peter H. Stone, Takashi Akasaka, David Erlinge, Hector M. Garcia-Garcia, Guillermo Tearney, Ron Waksman

September 23, 2018

Presentation TCT 2018

Case #2 Is it a Plaque Erosion or a Plaque Rupture (and How to Treat)?

Presenter: James E. Muller, Yoshinobu Onuma, Peter H. Stone, Takashi Akasaka, David Erlinge, Hector M. Garcia-Garcia, Guillermo Tearney, Ron Waksman

September 23, 2018

Presentation TCT 2018

Case #1 Spontaneous Coronary Dissection: To Stent or Not to Stent?

Presenter: James E. Muller, Yoshinobu Onuma, Peter H. Stone, Takashi Akasaka, David Erlinge, Hector M. Garcia-Garcia, Guillermo Tearney, Ron Waksman

September 23, 2018

Presentation TCT 2017

Novel Invasive Diagnostics II: NIRS-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, David Erlinge

November 01, 2017

Presentation TCT 2017

Prospects for Hypothermia to Reduce Infarct Size

Presenter: Bernard J. Gersh, Michel Ovize, David Erlinge

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Presentation TCT 2017

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Presenter: Michael S. Lee, Dirk Sibbing, David Erlinge

October 30, 2017

Presentation TCT 2017

Case #8: Unexpected Stent Failure Visualized by OCT (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Evelyn S. Regar

October 30, 2017

Presentation TCT 2017

Case #7: PCI Induced Intramural Hematoma Visualized by IVUS (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Itshac Itsik Ben-dor

October 30, 2017

Presentation TCT 2017

Case #6: Progression of Vulnerable Plaque by NIRS-IVUS: Should I Have Treated It? (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Ryan D. Madder

October 30, 2017

Presentation TCT 2017

Case #5: An Interesting Spontaneous Coronary Dissection Visualized by OCT (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Case #4: OCT Changed My Strategy of Calcified Lesion Stenting (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Jonathan M. Hill

October 30, 2017

Presentation TCT 2017

Case #3: IVUS Changed My Strategy of Left Main Stenting (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Ioannis Iakovou

October 30, 2017

Presentation TCT 2017

Case #2: Stent Sizing, Lesion Length Determination and Optimization by OCT (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Ulf Landmesser

October 30, 2017

Presentation TCT 2017

Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Azeem Latib

October 30, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

Presentation ESC 2017

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presenter: David Erlinge

August 27, 2017

Presentation TCT 2016

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Presenter: John A. Ambrose, Peter H. Stone, David Erlinge

November 01, 2016

Presentation TCT 2016

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols

Presenter: Cindy L. Grines, Holger Thiele, David Erlinge

October 31, 2016

Advertisement

Case #4 A Patient With a Vulnerable Plaque Who Developed a Late Event

Case #3 Vulnerable Plaque and Peri-Procedural Myocardial Infarction: I Should Have Used Protection

Case #2 Is it a Plaque Erosion or a Plaque Rupture (and How to Treat)?

Case #1 Spontaneous Coronary Dissection: To Stent or Not to Stent?

Novel Invasive Diagnostics II: NIRS-Based

Prospects for Hypothermia to Reduce Infarct Size

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Case #8: Unexpected Stent Failure Visualized by OCT (With Discussion)

Case #7: PCI Induced Intramural Hematoma Visualized by IVUS (With Discussion)

Case #6: Progression of Vulnerable Plaque by NIRS-IVUS: Should I Have Treated It? (With Discussion)

Case #5: An Interesting Spontaneous Coronary Dissection Visualized by OCT (With Discussion)

Case #4: OCT Changed My Strategy of Calcified Lesion Stenting (With Discussion)

Case #3: IVUS Changed My Strategy of Left Main Stenting (With Discussion)

Case #2: Stent Sizing, Lesion Length Determination and Optimization by OCT (With Discussion)

Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion)

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content